Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1981 1
1992 1
2004 3
2005 2
2006 4
2007 2
2008 4
2009 8
2010 7
2011 8
2012 11
2013 14
2014 10
2015 12
2016 8
2017 5
2018 1
2019 3
2020 2
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 28100689

100 results
Results by year
Filters applied: . Clear all
Page 1
Effectiveness and Duration of Protection of One Dose of a Meningococcal Conjugate Vaccine.
Cohn AC, MacNeil JR, Harrison LH, Lynfield R, Reingold A, Schaffner W, Zell ER, Plikaytis B, Wang X, Messonnier NE; Active Bacterial Core Surveillance (ABCs) Team and MeningNet Surveillance Partners. Cohn AC, et al. Pediatrics. 2017 Feb;139(2):e20162193. doi: 10.1542/peds.2016-2193. Pediatrics. 2017. PMID: 28100689 Free article.
Safety and immunogenicity of a booster dose of meningococcal (groups A, C, W, and Y) polysaccharide diphtheria toxoid conjugate vaccine.
Robertson CA, Greenberg DP, Hedrick J, Pichichero M, Decker MD, Saunders M. Robertson CA, et al. Vaccine. 2016 Oct 17;34(44):5273-5278. doi: 10.1016/j.vaccine.2016.09.003. Epub 2016 Sep 15. Vaccine. 2016. PMID: 27642132 Free article. Clinical Trial.
Immunogenicity and safety of a quadrivalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine (MenACWY-TT) administered to adults aged 56 Years and older: results of an open-label, randomized, controlled trial.
Dbaibo G, El-Ayoubi N, Ghanem S, Hajar F, Bianco V, Miller JM, Mesaros N. Dbaibo G, et al. Drugs Aging. 2013 May;30(5):309-19. doi: 10.1007/s40266-013-0065-0. Drugs Aging. 2013. PMID: 23494214 Free PMC article. Clinical Trial.
Antibody persistence and booster response of a quadrivalent meningococcal conjugate vaccine in adolescents.
Baxter R, Reisinger K, Block SL, Izu A, Odrljin T, Dull P. Baxter R, et al. J Pediatr. 2014 Jun;164(6):1409-15.e4. doi: 10.1016/j.jpeds.2014.02.025. Epub 2014 Mar 20. J Pediatr. 2014. PMID: 24657122 Clinical Trial.
Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP).
Cohn AC, MacNeil JR, Clark TA, Ortega-Sanchez IR, Briere EZ, Meissner HC, Baker CJ, Messonnier NE; Centers for Disease Control and Prevention (CDC). Cohn AC, et al. MMWR Recomm Rep. 2013 Mar 22;62(RR-2):1-28. MMWR Recomm Rep. 2013. PMID: 23515099 Free article.
Immunogenicity and immune memory of a nonadjuvanted quadrivalent meningococcal glycoconjugate vaccine in infants.
Perrett KP, Snape MD, Ford KJ, John TM, Yu LM, Langley JM, McNeil S, Dull PM, Ceddia F, Anemona A, Halperin SA, Dobson S, Pollard AJ. Perrett KP, et al. Pediatr Infect Dis J. 2009 Mar;28(3):186-93. doi: 10.1097/INF.0b013e31818e037d. Pediatr Infect Dis J. 2009. PMID: 19209097 Clinical Trial.
Immunogenicity of a tetravalent meningococcal glycoconjugate vaccine in infants: a randomized controlled trial.
Snape MD, Perrett KP, Ford KJ, John TM, Pace D, Yu LM, Langley JM, McNeil S, Dull PM, Ceddia F, Anemona A, Halperin SA, Dobson S, Pollard AJ. Snape MD, et al. JAMA. 2008 Jan 9;299(2):173-84. doi: 10.1001/jama.2007.29-c. JAMA. 2008. PMID: 18182599 Clinical Trial.
Immunogenicity, Safety and Antibody Persistence of a Booster Dose of Quadrivalent Meningococcal ACWY-tetanus Toxoid Conjugate Vaccine Compared with Monovalent Meningococcal Serogroup C Vaccine Administered Four Years After Primary Vaccination Using the Same Vaccines.
Vesikari T, Forsten A, Bianco V, Van der Wielen M, Miller JM. Vesikari T, et al. Pediatr Infect Dis J. 2015 Dec;34(12):e298-307. doi: 10.1097/INF.0000000000000897. Pediatr Infect Dis J. 2015. PMID: 26780033 Clinical Trial.
Persistence of antibodies for 42 months following vaccination of adolescents with a meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine (MenACWY-TT).
Østergaard L, Van der Wielen M, Bianco V, Miller JM. Østergaard L, et al. Int J Infect Dis. 2013 Mar;17(3):e173-6. doi: 10.1016/j.ijid.2012.10.001. Epub 2012 Dec 13. Int J Infect Dis. 2013. PMID: 23246368 Free article. Clinical Trial.
Phase III comparison of an investigational quadrivalent meningococcal conjugate vaccine with the licensed meningococcal ACWY conjugate vaccine in adolescents.
Jackson LA, Baxter R, Reisinger K, Karsten A, Shah J, Bedell L, Dull PM; V59P13 Study Group. Jackson LA, et al. Clin Infect Dis. 2009 Jul 1;49(1):e1-10. doi: 10.1086/599117. Clin Infect Dis. 2009. PMID: 19476428 Clinical Trial.
100 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback